The Most Effective Hormone Replacement Therapies
Genotropin® is the prescription human growth hormone made by Pfizer. It is a recombinant human growth hormone indicated for the treatment of children with growth failure due to GHD, Prader-Willi syndrome, Small for Gestational Age, Turner syndrome, and Idiopathic Short Stature, and for adults with either adult onset or a continuance of childhood onset GHD.
Genotropin® is available for use with a variety of proprietary injectable devices made by the manufacturer or with standard syringes. The injectable devices include the Genotropin® Multiuse Pen, and the Genotropin MiniQuick® pen. The Genotropin® Multiuse Pen features:
The Genotropin MiniQuick® pen is a preservative-free, pre-measured disposable pen featuring:
The above devices can be used to deliver 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1.0 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg, and 2.0 mg doses of Genotropin®.
The manufacturer also provides the Genotropin Mixer® which is a reusable device for use with 5-mg or 12-mg Genotropin® cartridges and standard syringes.
Clinical trails have demonstrated that Genotropin® is therapeutically equivalent to the human growth hormone produced by the pituitary origin. In children with GHD, Prader-Willi syndrome, or other conditions resulting in insufficient growth, Genotropin® stimulates linear growth. In adults with GHD, treatment with Genotropin® results in reduced fat mass, increased lean body mass, metabolic alterations that include beneficial changes in lipid metabolism, and normalization of IGF-I concentrations.
In addition to tissue growth, other documented benefits of Genotropin® include:
More common – some of the more common side effects of Genotropin® include: side injection site reactions, such as pain, redness/swelling, inflammation, bleeding, scarring, lumps, or rash. Other common side effects could be fat loss, headache, blood in the urine, low thyroid activity, and mildly increased blood sugar.
Less common – some of the potentially severe, though less common side effects of Genotropin® include:
See your medication’s insert for a complete list of potential side-effects.
Your prescription for Genotropin® will be tailored to best meet your particular goals and lifestyle. You will be carefully monitored over the course of your treatment with Genotropin®, so any chance of side effects should be kept to a minimum. Tell your doctor if you are experiencing any of these or other side effects while taking Genotropin®.
Overdose of Genotropin® can cause:
As with any medication, in case of accidental overdose, seek emergency medical attention or call the Poison Help line at 1-800-222-1222. Keep Genotropin® and all prescription medications out of the reach of children.
According to its manufacturer, Genotropin®:
Some patients have developed diabetes mellitus while taking Genotropin®. Dosage of diabetes medicines may need to be adjusted during growth hormone treatment.
Before accepting a prescription for Genotropin®, tell your doctor if you have a history of:
If you have diabetes, this drug may increase your blood sugar. Check your blood sugar regularly as directed and share the results with your doctor. Tell your doctor right away if you have symptoms of high blood sugar such as increased thirst/urination. Your doctor may need to adjust your diabetes medication, exercise program, or diet.
Check your products insert for a complete list of warnings, side-effects and contraindications of Genotropin®.
Genotropin® is injected into a muscle or under the skin. You will be shown exactly how to administer your Genotropin® injections. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles and syringes.
The manufacturer of Genotropin® offers several injection devices to best meet your individual needs. Complete instructions for the use of each delivery device may accessed here.
The manufacturer also provides an instructional video on how to use the Genotropin® MiniQuick Pen.
The daily dosage of Genotropin® varies by your age, weight and the condition it is being prescribed for. The weekly dose should be divided into 6 or 7 subcutaneous injections. According to the Prescribing Information provided by the National Institutes for Health, Genotropin® should be administered subcutaneously as follows:
*Dosing information is provided for informational purposes only, and should not be construed as any kind of instructions for use. Consult your physician or pharmacist for guidance regarding your particular dose of Genotropin®
Sources:
https://www.drugs.com/pro/genotropin.html
https://www.pfizermedicalinformation.com/en-us/genotropin/clinical-pharmacology